Oncolytics Biotech Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 01/08/2025 | 200,400 | $186,332 | 14.95% | 0.26% |
| SEEDS INVESTOR LLC | 02/13/2025 | 189,941 | $173,568 | 0.00% | 0.25% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 101,398 | $92,657 | 19.29% | 0.13% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 98,452 | $90,000 | 100.00% | 0.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 66,939 | $61,168 | 59.60% | 0.09% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 64,479 | $59,721 | 199.57% | 0.08% |
| ROYAL BANK OF CANADA | 02/14/2025 | 63,682 | $58,000 | -14.57% | 0.08% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 60,114 | $55,000 | -1.64% | 0.08% |
| CIBC WORLD MARKET INC. | 01/23/2025 | 58,680 | $54,000 | 1.46% | 0.08% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 39,231 | $36,252 | 3.45% | 0.05% |
| 01/24/2025 | 29,744 | $27,180 | 100.00% | 0.04% | |
| SEACREST WEALTH MANAGEMENT, LLC | 01/14/2025 | 26,000 | $23,759 | 0.00% | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 01/14/2025 | 25,000 | $23,122 | 0.00% | 0.03% |
| NEWMAN DIGNAN & SHEERAR, INC. | 01/30/2025 | 22,915 | $20,940 | 4.09% | 0.03% |
| UBS GROUP AG | 02/14/2025 | 20,898 | $19,101 | -8.89% | 0.03% |
| ROVIN CAPITAL /UT/ /ADV | 01/14/2025 | 20,620 | $19,000 | 0.00% | 0.03% |
| HEADINVEST, LLC | 02/18/2025 | 19,834 | $18,124 | 13.77% | 0.03% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 15,796 | $14,363 | 0.00% | 0.02% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 15,055 | $13,760 | 100.00% | 0.02% |
| AUSDAL FINANCIAL PARTNERS, INC. | 02/12/2025 | 15,000 | $13,707 | 7.14% | 0.02% |
| C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS | 01/31/2025 | 15,000 | $13,707 | 0.00% | 0.02% |
| CREATIVE PLANNING | 02/14/2025 | 13,330 | $12,181 | 29.04% | 0.02% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 12,666 | $11,704 | 100.00% | 0.02% |
| KINGSVIEW WEALTH MANAGEMENT, LLC | 01/28/2025 | 12,000 | $10,966 | 9.09% | 0.02% |
| PFG INVESTMENTS, LLC | 01/22/2025 | 10,925 | $9,983 | 4.05% | 0.01% |
| PROFESSIONAL ADVISORY SERVICES INC | 01/15/2025 | 10,000 | $9,000 | 0.00% | 0.01% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 8,452 | $7,438 | 322.60% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 7,800 | $7,128 | -43.11% | 0.01% |
| CEDAR MOUNTAIN ADVISORS, LLC | 01/21/2025 | 5,651 | $5,164 | 0.00% | 0.01% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 5,000 | $4,569 | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 4,401 | $4,021 | 0.00% | 0.01% |
| 02/20/2025 | 4,393 | $4,000 | 100.00% | 0.01% | |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3,000 | $2,741 | 100.00% | 0.00% |
| IFP ADVISORS, INC | 02/04/2025 | 2,504 | $2,288 | 0.16% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 2,045 | $1,799 | -75.93% | 0.00% |
| CWM, LLC | 02/04/2025 | 1,325 | $1,000 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 1,000 | $914 | 100.00% | 0.00% |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 02/10/2025 | 825 | $754 | 100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 02/13/2025 | 557 | $507 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 526 | $481 | 100.00% | 0.00% |
| JNBA FINANCIAL ADVISORS | 01/30/2025 | 210 | $192 | 0.00% | 0.00% |
| 03/04/2025 | 146 | $133 | 100.00% | 0.00% | |
| AVISO FINANCIAL INC. | 02/10/2025 | 52 | $48 | 0.00% | 0.00% |
| WOLFF WIESE MAGANA LLC | 01/14/2025 | 31 | $29 | 0.00% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oncolytics Biotech Inc. institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of Oncolytics Biotech Inc.. The most heavily invested institutionals were:
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 200,400
SEEDS INVESTOR LLC: 189,941
GOLDMAN SACHS GROUP INC: 101,398
Virtu Financial LLC: 98,452
GEODE CAPITAL MANAGEMENT, LLC: 66,939
NATIONAL BANK OF CANADA /FI/: 64,479
1.73% of Oncolytics Biotech Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.37 M shares in the last 24 months. This purchase volume represents approximately $1.27 M in transactions.